Arsenic trioxide-induced growth arrest of breast cancer MCF-7 cells involving FOXO3a and IκB Kinase β expression and localization

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 8, 2012, Pages 504-512

  Liu, Wenlou ^a,b   Gong, Yusen ^a   Li, Haili ^a   Jiang, Guan ^a,c   Zhan, Shining ^a   Liu, Hong ^a   Wu, Yongping ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c Center for Disease Control and Prevention of Xuzhou City   (China)

Author keywords

arsenic trioxide (As2O3; breast cancer; cell apoptosis; FOXO3a localization; I B kinase (IKK )

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; I KAPPA B KINASE BETA; MESSENGER RNA; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL NUCLEUS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; ARSENICALS; BREAST NEOPLASMS; CASPASE 3; CELL GROWTH PROCESSES; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GROWTH INHIBITORS; HUMANS; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; MCF-7 CELLS; OXIDES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867563508     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1162     Document Type: Article

References (35)

1. Evens AM, Tallman MS, Gartenhaus RB. The potential of arsenic trioxide in the treatment of malignant disease: Past, present, and future. Leuk Res 2004;28:891.
2. Ye J, Li A, Liu Q, et al. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. Clin Exp Pharmacol Physiol 2005;32:1042.
3. Chow SK, Chan JY, Fung KP. Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells. J Cell Biochem 2004;93:173.
4. Platanias LC. Biological responses to arsenic compounds. J Biol Chem 2009;284:18583.
5. Weigel D, Jü rgens G, Kü ttner F, et al. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 1989;57:645.
6. You H, Pellegrini M, Tsuchihara K, et al. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med 2006;203:1657.
7. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci 2007;120:2479.
8. Tang ED, Nunez G, Barr FG, et al. Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 1999;274:16741.
9. Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 2003;73:689.
10. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421.
11. Rosas M, Birkenkamp KU, Lammers JW, et al. Cytokine mediated suppression of TF-1 apoptosis requires PI3K activation and inhibition of Bim expression. FEBS Lett 2005;579:191.
12. Chen J, Yusuf I, Andersen HM, et al. FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytes. J Immunol 2006;176: 2711.
13. Segrelles C, Moral M, Lara MF, et al. Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006;25:1174.
14. Yang JY, Xia W, Hu MC. Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. Int J Oncol 2006;29:643.
15. Chen YJ, Hsiao PW, Lee MT, et al. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J Endocrinol 2007;192: 405.
16. Tsai WB, Chung YM, Takahashi Y, et al. Functional interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 2008;10:460.
17. Sakoe Y, Sakoe K, Kirito K, et al. FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia. Blood 2010;115:3787.
18. Sunters A, Ferna'ndez de Mattos S, et al. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 2003;278:49795.
19. Hughes R, Kristiansen M, Lassot I, et al. NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons. Cell Death Differ 2010;18:937.
20. Radisavljevic Z. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells. Cancer 2003;97:1358.
21. Smith WW, Norton DD, Gorospe M, et al. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J Cell Biol 2005;169:331.
22. Cornforth AN, Davis JS, Khanifar E, et al. FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene 2008;27:4422.
23. Dubrovska A, Kim S, Salamone RJ, et al. The role of PTEN/ Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A 2009;106:268.
24. Ghosh S, Karin M. Missing pieces in the NF-jB puzzle. Cell 2002;109:S81.
25. Zagzag D, Salnikow K, Chiribogal L, et al. Downregulation of major histocompatibility complex antigens in invading glioma cells: Stealth invasion of the brain. Lab Invest 2005;85:328.
26. Jackson-Bernitsas DG, Ichikawa H, Takada Y, et al. Evidence that TNF-TNFR1-TRAD-D-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007;26:1385.
27. Mann KK, Colombo M, Miller WH, Jr. Arsenic trioxide decreases AKT protein in a caspase-dependent manner. Mol Cancer Ther 2008;7:1680.
28. Ho SY, Chen WC, Chiu HW, et al. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation. Chem Biol Interact 2009;179:304.
29. Jin G-S, Kondo E, Miyake T, et al. Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. Acta Med Okayama 2004;58:197.
30. Bu DX, Erl W, de Martin R, et al. IKKbeta-dependent NFkappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J 2005;19:1293.
31. Hu MC, Lee DF, Xia W, et al. IjB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004;117:225.
32. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: Mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004;380:297.
33. Rena G, Woods YL, Prescott AR, et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 2002;21:2263.
34. Chong ZZ, Maiese K. Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br J Pharmacol 2007;150:839.
35. Wang Y, Oh SW, Deplancke B, et al. C. elegans 14-3-3 proteins regulate life span and interact with SIR-2.1 and DAF- 16/FOXO. Mech Ageing Dev 2006;127:741.